Association between serum ligands and the skin toxicity of anti‐epidermal growth factor receptor antibody in metastatic colorectal cancer-Reference-Cited by-同舟云学术

Association between serum ligands and the skin toxicity of anti‐epidermal growth factor receptor antibody in metastatic colorectal cancer

Published:2015-04-29 Issue:5 Volume:106 Page:604-610
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Takahashi Naoki¹^ORCID,Yamada Yasuhide¹,Furuta Koh²,Nagashima Kengo³,Kubo Akiko⁴,Sasaki Yusuke¹,Shoji Hirokazu¹,Honma Yoshitaka¹,Iwasa Satoru¹,Okita Natsuko¹,Takashima Atsuo¹,Kato Ken¹,Hamaguchi Tetsuya¹,Shimada Yasuhiro¹⁵

Affiliation:

1. Division of Gastrointestinal Oncology National Cancer Center Hospital Tokyo Japan

2. Division of Clinical Laboratories National Cancer Center Hospital TokyoJapan

3. Clinical Research Center Chiba University Hospital ChibaJapan

4. Division of Pharmacy National Cancer Center Hospital TokyoJapan

5. Division of Medical Oncology Kochi Health Sciences Center Kouch Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12642

Reference24 articles.

1. Cetuximab for the Treatment of Colorectal Cancer

2. Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

3. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

4. KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

5. Promising biomarkers for predicting the outcomes of patients withKRASwild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A systematic review with meta-analysis

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Preliminary Study Examining the Correlation between EGFRI Treatment, Clinic Dermatoscopy Features, and Serum Levels of Anti-Alpha-Galactosyl IgE in Colorectal Cancer Patients;Gastroenterology Insights;2024-06-17

2. Evaluation of the additional prophylactic effect of topical steroid ointment to systemic minocycline against anti-epidermal growth factor antibody-induced skin toxicities in metastatic colorectal cancer treatment;Supportive Care in Cancer;2023-12-06

3. Evaluation of the additional prophylactic effect of topical steroid ointment to systemic minocycline against anti-epidermal growth factor antibody-induced skin toxicities in metastatic colorectal cancer treatment;2023-08-11

4. Risk factor analysis for anti-epidermal growth factor receptor monoclonal antibody–induced skin toxicities in real-world metastatic colorectal cancer treatment;Supportive Care in Cancer;2023-08

5. Is there any clinical or laboratory predictive factor for cetuximab-induced skin toxicity?;Expert Opinion on Drug Safety;2021-03-05